These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38229174)

  • 1. Intracellular delivery of Parkin-RING0-based fragments corrects Parkin-induced mitochondrial dysfunction through interaction with SLP-2.
    Zanon A; Guida M; Lavdas AA; Corti C; Castelo Rueda MP; Negro A; Pramstaller PP; Domingues FS; Hicks AA; Pichler I
    J Transl Med; 2024 Jan; 22(1):59. PubMed ID: 38229174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila.
    Zanon A; Kalvakuri S; Rakovic A; Foco L; Guida M; Schwienbacher C; Serafin A; Rudolph F; Trilck M; Grünewald A; Stanslowsky N; Wegner F; Giorgio V; Lavdas AA; Bodmer R; Pramstaller PP; Klein C; Hicks AA; Pichler I; Seibler P
    Hum Mol Genet; 2017 Jul; 26(13):2412-2425. PubMed ID: 28379402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin Deficiency Impairs Mitochondrial DNA Dynamics and Propagates Inflammation.
    Wasner K; Smajic S; Ghelfi J; Delcambre S; Prada-Medina CA; Knappe E; Arena G; Mulica P; Agyeah G; Rakovic A; Boussaad I; Badanjak K; Ohnmacht J; Gérardy JJ; Takanashi M; Trinh J; Mittelbronn M; Hattori N; Klein C; Antony P; Seibler P; Spielmann M; Pereira SL; Grünewald A
    Mov Disord; 2022 Jul; 37(7):1405-1415. PubMed ID: 35460111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.
    Hristova VA; Beasley SA; Rylett RJ; Shaw GS
    J Biol Chem; 2009 May; 284(22):14978-86. PubMed ID: 19339245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin.
    Yang H; Zhou X; Liu X; Yang L; Chen Q; Zhao D; Zuo J; Liu W
    Biochem Biophys Res Commun; 2011 Jun; 410(1):114-20. PubMed ID: 21640711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of the effects of mutations in Ubl domain of Parkin leading to Parkinson's disease.
    Biswas S; Roy R; Biswas R; Bagchi A
    Gene; 2020 Feb; 726():144186. PubMed ID: 31647998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neurons.
    Rakovic A; Shurkewitsch K; Seibler P; Grünewald A; Zanon A; Hagenah J; Krainc D; Klein C
    J Biol Chem; 2013 Jan; 288(4):2223-37. PubMed ID: 23212910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.
    González-Casacuberta I; Morén C; Juárez-Flores DL; Esteve-Codina A; Sierra C; Catalán-García M; Guitart-Mampel M; Tobías E; Milisenda JC; Pont-Sunyer C; Martí MJ; Cardellach F; Tolosa E; Artuch R; Ezquerra M; Fernández-Santiago R; Garrabou G
    Neurobiol Aging; 2018 May; 65():206-216. PubMed ID: 29501959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin Interacts with Apoptosis-Inducing Factor and Interferes with Its Translocation to the Nucleus in Neuronal Cells.
    Guida M; Zanon A; Montibeller L; Lavdas AA; Ladurner J; Pischedda F; Rakovic A; Domingues FS; Piccoli G; Klein C; Pramstaller PP; Hicks AA; Pichler I
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endoplasmic reticulum-mitochondria interface is perturbed in PARK2 knockout mice and patients with PARK2 mutations.
    Gautier CA; Erpapazoglou Z; Mouton-Liger F; Muriel MP; Cormier F; Bigou S; Duffaure S; Girard M; Foret B; Iannielli A; Broccoli V; Dalle C; Bohl D; Michel PP; Corvol JC; Brice A; Corti O
    Hum Mol Genet; 2016 Jul; 25(14):2972-2984. PubMed ID: 27206984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design and characterization of Parkin-activating mutations.
    Stevens MU; Croteau N; Eldeeb MA; Antico O; Zeng ZW; Toth R; Durcan TM; Springer W; Fon EA; Muqit MM; Trempe JF
    Life Sci Alliance; 2023 Jun; 6(6):. PubMed ID: 36941054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive computational study on pathogenic mis-sense mutations spanning the RING2 and REP domains of Parkin protein.
    Biswas R; Bagchi A
    Gene; 2017 Apr; 610():49-58. PubMed ID: 28189762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial impairment observed in fibroblasts from South African Parkinson's disease patients with parkin mutations.
    van der Merwe C; Loos B; Swart C; Kinnear C; Henning F; van der Merwe L; Pillay K; Muller N; Zaharie D; Engelbrecht L; Carr J; Bardien S
    Biochem Biophys Res Commun; 2014 May; 447(2):334-40. PubMed ID: 24721425
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wauters F; Cornelissen T; Imberechts D; Martin S; Koentjoro B; Sue C; Vangheluwe P; Vandenberghe W
    Autophagy; 2020 Feb; 16(2):203-222. PubMed ID: 30945962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitasking guardian of mitochondrial quality: Parkin function and Parkinson's disease.
    Kamienieva I; Duszyński J; Szczepanowska J
    Transl Neurodegener; 2021 Jan; 10(1):5. PubMed ID: 33468256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release.
    Berger AK; Cortese GP; Amodeo KD; Weihofen A; Letai A; LaVoie MJ
    Hum Mol Genet; 2009 Nov; 18(22):4317-28. PubMed ID: 19679562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
    Koentjoro B; Park JS; Sue CM
    Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations.
    González-Casacuberta I; Juárez-Flores DL; Ezquerra M; Fucho R; Catalán-García M; Guitart-Mampel M; Tobías E; García-Ruiz C; Fernández-Checa JC; Tolosa E; Martí MJ; Grau JM; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
    Aging (Albany NY); 2019 Jun; 11(11):3750-3767. PubMed ID: 31180333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-β hydroxysteroid dehydrogenase type 10.
    Bertolin G; Jacoupy M; Traver S; Ferrando-Miguel R; Saint Georges T; Grenier K; Ardila-Osorio H; Muriel MP; Takahashi H; Lees AJ; Gautier C; Guedin D; Coge F; Fon EA; Brice A; Corti O
    Cell Death Differ; 2015 Oct; 22(10):1563-76. PubMed ID: 25591737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.